ImmunoGen, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ImmunoGen, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2023.
  • ImmunoGen, Inc. Debt-to-equity for the quarter ending September 30, 2023 was 63.4 %, a 7.77% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 63.4 -5.34 -7.77% Sep 30, 2023
Q2 2023 80.7 +0.65 +0.81% Jun 30, 2023
Q1 2023 101 -5.47 -5.14% Mar 31, 2023
Q4 2022 81.1 -79 -49.3% Dec 31, 2022
Q3 2022 68.8 -226 -76.7% Sep 30, 2022
Q2 2022 80 -418 -83.9% Jun 30, 2022
Q1 2022 106 -842 -88.8% Mar 31, 2022
Q4 2021 160 -6.23K -97.5% Dec 31, 2021
Q3 2021 295 +1.11K Sep 30, 2021
Q2 2021 498 +1.15K Jun 30, 2021
Q1 2021 948 +1.51K Mar 31, 2021
Q4 2020 6.39K +6.92K Dec 31, 2020
Q3 2020 -812 -33.5 -4.3% Sep 30, 2020
Q2 2020 -654 +2.73K +80.7% Jun 30, 2020
Q1 2020 -559 -1.58K -155% Mar 31, 2020
Q4 2019 -527 -1.58K -150% Dec 31, 2019
Q3 2019 -779 -2.24K -153% Sep 30, 2019
Q2 2019 -3.39K -1.76K -108% Jun 30, 2019
Q1 2019 1.02K +1.41K Mar 31, 2019
Q4 2018 1.06K +1.34K Dec 31, 2018
Q3 2018 1.46K +1.69K Sep 30, 2018
Q2 2018 -1.63K -1.4K -621% Jun 30, 2018
Q1 2018 -385 -119 -44.8% Mar 31, 2018
Q4 2017 -284 +49.6 +14.9% Dec 31, 2017
Q3 2017 -227 +248 +52.2% Sep 30, 2017
Q2 2017 -226 +682 +75.1% Jun 30, 2017
Q1 2017 -266 +9.44K +97.3% Mar 31, 2017
Q4 2016 -334 -1.33K -134% Dec 31, 2016
Q3 2016 -475 -840 -230% Sep 30, 2016
Q2 2016 -908 -1.12K -535% Jun 30, 2016
Q1 2016 -9.71K -9.82K -8924% Mar 31, 2016
Q4 2015 992 +891 +881% Dec 31, 2015
Q3 2015 366 +273 +296% Sep 30, 2015
Q2 2015 209 +130 +166% Jun 30, 2015
Q1 2015 110 +38.9 +54.7% Mar 31, 2015
Q4 2014 101 +35.6 +54.3% Dec 31, 2014
Q3 2014 92.4 +23.3 +33.7% Sep 30, 2014
Q2 2014 78.3 +11.3 +16.8% Jun 30, 2014
Q1 2014 71.1 -1.81 -2.48% Mar 31, 2014
Q4 2013 65.6 -14.4 -18% Dec 31, 2013
Q3 2013 69.1 -14 -16.8% Sep 30, 2013
Q2 2013 67.1 -17.9 -21% Jun 30, 2013
Q1 2013 72.9 +1.8 +2.53% Mar 31, 2013
Q4 2012 79.9 Dec 31, 2012
Q3 2012 83.1 Sep 30, 2012
Q2 2012 84.9 Jun 30, 2012
Q1 2012 71.1 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.